Preclinical Evidence for Combined Use of Aromatase Inhibitors and NSAIDs as Preventive Agents of Tobacco-Induced Lung Cancer

INTRODUCTION: A hormonal role in non-small cell lung cancer (NSCLC) development is well documented. We previously showed that the aromatase inhibitor (AI) anastrozole decreased the development of tobacco carcinogen-induced lung tumors in a murine lung cancer prevention model and that aromatase and e...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Thorac Oncol
Autores principales: Stabile, Laura P., Farooqui, Mariya, Kanterewicz, Beatriz, Abberbock, Shira, Kurland, Brenda F., Diergaarde, Brenda, Siegfried, Jill M.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5825271/
https://ncbi.nlm.nih.gov/pubmed/29233790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2017.11.126
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares